• +91-11-47589500
  • info@medicamen.com

Key Milestones

MEDICAMEN Biotech has constantly strived to be on the path of growth on the strength of its brilliant human resource, world class facilities and a global vision of its Management.

From being a purely Formulation manufacturer of general products, the Company has diversified into setting up a state-of-the-art R&D Centre followed by a most modern API manufacturing facility and, lastly, setting up a highly auditable facility for manufacturing Oncology injectables and OSDs which will stand the test of leading global regulatory agencies. Please find below our journey from humble beginnings to being a vertically integrated Group:

Chronology of Events


  • Achievements

  • 1993

    Medicamen established.

  • 1995

    IPO issued – BSE listed.

  • 1996

    Operations started - Bhiwadi FDF Plant

  • 1998

    WHO-GMP Received – Bhiwadi FDF Plant

  • 2000

    ISO certification – Bhiwadi FDF Plant

  • Achievements

  • 2001: Global Accreditation

    NDA(Uganda), ANVISA(Brazil),FM HACA( Ethiopia)-Bhiwadi FDF Plant

  • 2007

    Operations started – Haridwar Unit-I (FDF)

  • Achievements

  • 2018

    New R&D center setup along with Upgradation & Mordernization of Bhiwadi FDF plant

  • 2016

    Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd

  • 2019: Global Accreditation

    FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant

  • 2020

    Global API Facility started– Dahej API Plant

  • Achievements

  • 2021

    Operations started: Haridwar formulation Unit –II(FDF) (oncology)

  • 2021

    Filing API USDMFs & CEPs

Copyright © 2023, MEDICAMEN BIOTECH LIMITED. All Rights Reserved.   Designed by Rautela Tech